Published in Br J Pharmacol on March 15, 2004
Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med (2009) 1.43
TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein. J Biol Chem (2010) 1.41
Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol (2006) 1.07
Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1. Br J Pharmacol (2009) 1.01
Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models. Microb Pathog (2007) 0.93
Inhibition of polyadenylation reduces inflammatory gene induction. RNA (2012) 0.89
Prostaglandin E(2) couples through EP(4) prostanoid receptors to induce IL-8 production in human colonic epithelial cell lines. Br J Pharmacol (2009) 0.89
(R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol (2005) 0.86
Biphasic effect of extracellular ATP on human and rat airways is due to multiple P2 purinoceptor activation. Respir Res (2005) 0.79
Prostaglandin E2 enhances the sensitizing effect of hyperthermia on pulmonary C-fibers in rats. Respir Physiol Neurobiol (2006) 0.78
The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor. Br J Pharmacol (2016) 0.77
Prostanoids and the cough reflex. Lung (2009) 0.76
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J (2000) 22.23
Prostanoid receptors: structures, properties, and functions. Physiol Rev (1999) 8.60
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev (1994) 5.11
The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood (1986) 4.47
Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol (2001) 4.40
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest (1986) 3.78
Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature (1993) 2.91
Guanosine cyclic 3',5'-phosphate dependent protein kinase, a chimeric protein homologous with two separate protein families. Biochemistry (1984) 2.62
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol (1997) 2.44
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta (2000) 2.37
Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem (1992) 2.19
The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology (2000) 2.08
Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol (1986) 1.98
Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br J Pharmacol (1986) 1.92
AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Br J Pharmacol (1988) 1.82
Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem (2002) 1.80
A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins (1994) 1.76
Pharmacology of the eosinophil. Pharmacol Rev (1999) 1.73
Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br J Pharmacol (1992) 1.58
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol (1997) 1.56
Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J Biol Chem (1996) 1.45
Function of prostanoid receptors: studies on knockout mice. Prostaglandins Other Lipid Mediat (2002) 1.44
pAx and competitive drug antagonism. Br J Pharmacol Chemother (1949) 1.38
New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors. Adv Prostaglandin Thromboxane Leukot Res (1987) 1.35
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol (2001) 1.35
A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods (1993) 1.29
6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochem Pharmacol (1995) 1.25
Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol (1997) 1.24
Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J (2001) 1.24
A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J Biol Chem (1989) 1.22
Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Am J Physiol (1999) 1.20
Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol (2002) 1.17
Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem (1986) 1.16
Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol Sci (1997) 1.12
Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat (2002) 1.11
Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Prostaglandins (1986) 1.08
The granulocyte-macrophage colony stimulating factors. Cell (1985) 1.08
Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. Am J Respir Cell Mol Biol (2001) 1.07
Characterization of PKIgamma, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase. J Biol Chem (1997) 1.05
Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells. J Immunol (2002) 1.05
Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol (1997) 1.03
Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Br J Pharmacol (1996) 1.01
Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther (2004) 0.97
Evidence for two additional isoforms of the endogenous protein kinase inhibitor of cAMP-dependent protein kinase in mouse. J Biol Chem (1993) 0.97
Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase. J Biol Chem (1991) 0.94
Design and synthesis of a highly selective EP2-receptor agonist. Bioorg Med Chem Lett (2001) 0.84
Release of GM-CSF and G-CSF by human arterial and venous smooth muscle cells: differential regulation by COX-2. Br J Pharmacol (2000) 0.82
Inhibitory prostanoid EP receptors in human non-pregnant myometrium. Eur J Pharmacol (1999) 0.80
Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid. Dig Dis Sci (1991) 0.77
Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med (2006) 8.98
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84
Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation (2011) 3.18
Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet (2012) 3.07
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68
Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics (2007) 2.49
Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation (2007) 2.24
A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med (2008) 2.10
Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest (2003) 2.04
Burkitt's lymphoma. Lancet (2012) 2.02
Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet (2010) 1.95
Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol (2009) 1.85
Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol (2013) 1.84
Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog (2010) 1.82
Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J (2006) 1.78
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol (2004) 1.77
The cardiac valve interstitial cell. Int J Biochem Cell Biol (2003) 1.76
Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation (2006) 1.75
Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol (2010) 1.72
Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One (2008) 1.70
Bronchodilator activity of bitter tastants in human tissue. Nat Med (2011) 1.69
Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol (2009) 1.65
The Ross procedure: a systematic review and meta-analysis. Circulation (2008) 1.65
Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis (2004) 1.64
Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol (2007) 1.61
Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging (2010) 1.61
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng (2006) 1.57
Establishing pediatric cardiovascular services in the developing world: a wake-up call. Circulation (2007) 1.54
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr (2013) 1.51
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol Ther (2011) 1.50
Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer (2008) 1.49
TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med (2009) 1.49
Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res (2006) 1.47
Sports-science roundtable: does sports-science research influence practice? Int J Sports Physiol Perform (2006) 1.44
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation. J Thorac Cardiovasc Surg (2003) 1.43
Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med (2009) 1.43
Louisiana (LA) Health: design and methods for a childhood obesity prevention program in rural schools. Contemp Clin Trials (2008) 1.43
Bridge to recovery: what remains to be discovered? Cardiol Clin (2011) 1.42
Development of an in vivo ischemia-reperfusion model in heterotopically transplanted rat hearts. Transplantation (2002) 1.40
ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2002) 1.39
Preserved homograft function 32 years after surgery in a young patient. J Thorac Cardiovasc Surg (2010) 1.38
Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J (2004) 1.38
Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol (2008) 1.38
Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg (2002) 1.37
Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis (2005) 1.36
Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater (2013) 1.34
P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One (2011) 1.33
Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem (2009) 1.32
Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol (2007) 1.31
Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease. Heart (2008) 1.29
Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res (2008) 1.28
Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med (2005) 1.24
Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer (2003) 1.24
Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. Am J Physiol Lung Cell Mol Physiol (2004) 1.24
The structure and function of cardiac t-tubules in health and disease. Proc Biol Sci (2011) 1.23
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol Ther (2006) 1.23
Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun (2007) 1.23
Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor. Cancer Res (2008) 1.22
A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2007) 1.22
Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg (2003) 1.17
Cytoskeletal protein 4.1R affects repolarization and regulates calcium handling in the heart. Circ Res (2008) 1.17
The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials (2012) 1.16
EP4 receptor as a new target for bronchodilator therapy. Thorax (2011) 1.16
Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg (2012) 1.15
Genetic background affects function and intracellular calcium regulation of mouse hearts. Cardiovasc Res (2010) 1.15
Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation (2002) 1.15
Theobromine inhibits sensory nerve activation and cough. FASEB J (2004) 1.15
Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J (2004) 1.13
Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation (2004) 1.12
Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors. J Pharmacol Exp Ther (2007) 1.11
Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation (2005) 1.10
Neglected diseases in cardiology: a call for urgent action. Nat Clin Pract Cardiovasc Med (2008) 1.10
Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation (2006) 1.10
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng (2006) 1.10
A review of preventative methods against human leishmaniasis infection. PLoS Negl Trop Dis (2013) 1.09
Contemporary use of ventricular assist devices. Annu Rev Med (2010) 1.09
The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol (2004) 1.09
Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings. Infect Agent Cancer (2010) 1.09
Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A (2004) 1.08
Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation (2004) 1.08
Mechanical unloading reverses transverse tubule remodelling and normalizes local Ca(2+)-induced Ca(2+)release in a rodent model of heart failure. Eur J Heart Fail (2012) 1.08
High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol (2003) 1.07
Expression of follistatin-related genes is altered in heart failure. Endocrinology (2008) 1.07
Phorbol ester-stimulated NF-kappaB-dependent transcription: roles for isoforms of novel protein kinase C. Cell Signal (2008) 1.07
Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol (2013) 1.07
Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes. Mol Pharmacol (2004) 1.07
A role for sensory nerves in the late asthmatic response. Thorax (2011) 1.06
Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways. Respir Res (2003) 1.06
Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A (2009) 1.06
30-year outcome of anatomic correction of anomalous origin of the left coronary artery from the pulmonary artery. J Am Coll Cardiol (2011) 1.06
ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils. Biochim Biophys Acta (2012) 1.05
Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol (2008) 1.05
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J (2004) 1.04